{"entity":{"type":"insider","cik":"0001554194","url":"/insider/0001554194","json_url":"/insider/0001554194.json","name":"Talbot George Harrison","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":5,"first":"2017-05-17","last":"2018-08-02","span_basis":"filed_date"},"name_variants":[{"name":"Talbot George Harrison","source":"filing","n_filings":5,"first_seen":"2017-05-17","last_seen":"2018-08-02"}],"transactions":[{"id":6649063,"accession":"0001104659-18-049251","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-049251","line_url":"/filing/0001104659-18-049251#line-1","is_derivative":false,"issuer_cik":"0001554194","issuer_name":"Nabriva Therapeutics plc","issuer_ticker":"NBRV","issuer_name_source":null,"issuer_url":"/issuer/0001554194","owner_cik":"0001554194","owner_name":"Talbot George Harrison","owner_url":"/insider/0001554194","role":"Director","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14500.0,"shares_display":"14,500","price_per_share":2.75,"price_display":"2.75","price_state":"stated","total_value":39875.0,"total_display":"39,875.00","shares_owned_after":47640.0,"shares_owned_after_display":"47,640","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-31","filed_date":"2018-08-02","scope":"insider"},{"id":5014505,"accession":"0001104659-17-040238","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-17-040238","line_url":"/filing/0001104659-17-040238#line-3","is_derivative":false,"issuer_cik":"0001554194","issuer_name":"Nabriva Therapeutics AG","issuer_ticker":"NBRV","issuer_name_source":null,"issuer_url":"/issuer/0001554194","owner_cik":"0001554194","owner_name":"Talbot George Harrison","owner_url":"/insider/0001554194","role":"Director","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46.0,"shares_display":"46","price_per_share":91.0,"price_display":"91.00","price_state":"stated","total_value":4186.0,"total_display":"4,186.00","shares_owned_after":3179.0,"shares_owned_after_display":"3,179","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-19","filed_date":"2017-06-19","scope":"insider"},{"id":5014500,"accession":"0001104659-17-040238","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-17-040238","line_url":"/filing/0001104659-17-040238#line-2","is_derivative":false,"issuer_cik":"0001554194","issuer_name":"Nabriva Therapeutics AG","issuer_ticker":"NBRV","issuer_name_source":null,"issuer_url":"/issuer/0001554194","owner_cik":"0001554194","owner_name":"Talbot George Harrison","owner_url":"/insider/0001554194","role":"Director","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24.0,"shares_display":"24","price_per_share":93.5,"price_display":"93.50","price_state":"stated","total_value":2244.0,"total_display":"2,244.00","shares_owned_after":3225.0,"shares_owned_after_display":"3,225","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-16","filed_date":"2017-06-19","scope":"insider"},{"id":5014495,"accession":"0001104659-17-040238","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-040238","line_url":"/filing/0001104659-17-040238#line-1","is_derivative":false,"issuer_cik":"0001554194","issuer_name":"Nabriva Therapeutics AG","issuer_ticker":"NBRV","issuer_name_source":null,"issuer_url":"/issuer/0001554194","owner_cik":"0001554194","owner_name":"Talbot George Harrison","owner_url":"/insider/0001554194","role":"Director","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":94.1,"price_display":"94.10","price_state":"stated","total_value":9410.0,"total_display":"9,410.00","shares_owned_after":3249.0,"shares_owned_after_display":"3,249","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-15","filed_date":"2017-06-19","scope":"insider"},{"id":4183829,"accession":"0001104659-17-037045","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-17-037045","line_url":"/filing/0001104659-17-037045#line-2","is_derivative":false,"issuer_cik":"0001554194","issuer_name":"Nabriva Therapeutics AG","issuer_ticker":"NBRV","issuer_name_source":null,"issuer_url":"/issuer/0001554194","owner_cik":"0001554194","owner_name":"Talbot George Harrison","owner_url":"/insider/0001554194","role":"Director","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":110.0,"shares_display":"110","price_per_share":101.5,"price_display":"101.50","price_state":"stated","total_value":11165.0,"total_display":"11,165.00","shares_owned_after":3449.0,"shares_owned_after_display":"3,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-30","filed_date":"2017-06-01","scope":"insider"},{"id":4183826,"accession":"0001104659-17-037045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-037045","line_url":"/filing/0001104659-17-037045#line-1","is_derivative":false,"issuer_cik":"0001554194","issuer_name":"Nabriva Therapeutics AG","issuer_ticker":"NBRV","issuer_name_source":null,"issuer_url":"/issuer/0001554194","owner_cik":"0001554194","owner_name":"Talbot George Harrison","owner_url":"/insider/0001554194","role":"Director","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":101.0,"price_display":"101.00","price_state":"stated","total_value":10100.0,"total_display":"10,100.00","shares_owned_after":3349.0,"shares_owned_after_display":"3,349","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-30","filed_date":"2017-06-01","scope":"insider"},{"id":5014393,"accession":"0001104659-17-035349","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-17-035349","line_url":"/filing/0001104659-17-035349#line-3","is_derivative":false,"issuer_cik":"0001554194","issuer_name":"Nabriva Therapeutics AG","issuer_ticker":"NBRV","issuer_name_source":null,"issuer_url":"/issuer/0001554194","owner_cik":"0001554194","owner_name":"Talbot George Harrison","owner_url":"/insider/0001554194","role":"Director","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":205.0,"shares_display":"205","price_per_share":100.5,"price_display":"100.50","price_state":"stated","total_value":20602.5,"total_display":"20,602.50","shares_owned_after":3649.0,"shares_owned_after_display":"3,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-25","filed_date":"2017-05-25","scope":"insider"},{"id":5014388,"accession":"0001104659-17-035349","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-17-035349","line_url":"/filing/0001104659-17-035349#line-2","is_derivative":false,"issuer_cik":"0001554194","issuer_name":"Nabriva Therapeutics AG","issuer_ticker":"NBRV","issuer_name_source":null,"issuer_url":"/issuer/0001554194","owner_cik":"0001554194","owner_name":"Talbot George Harrison","owner_url":"/insider/0001554194","role":"Director","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90.0,"shares_display":"90","price_per_share":101.0,"price_display":"101.00","price_state":"stated","total_value":9090.0,"total_display":"9,090.00","shares_owned_after":3559.0,"shares_owned_after_display":"3,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-25","filed_date":"2017-05-25","scope":"insider"},{"id":5014382,"accession":"0001104659-17-035349","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-035349","line_url":"/filing/0001104659-17-035349#line-1","is_derivative":false,"issuer_cik":"0001554194","issuer_name":"Nabriva Therapeutics AG","issuer_ticker":"NBRV","issuer_name_source":null,"issuer_url":"/issuer/0001554194","owner_cik":"0001554194","owner_name":"Talbot George Harrison","owner_url":"/insider/0001554194","role":"Director","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30.0,"shares_display":"30","price_per_share":99.7,"price_display":"99.70","price_state":"stated","total_value":2991.0,"total_display":"2,991.00","shares_owned_after":3854.0,"shares_owned_after_display":"3,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-23","filed_date":"2017-05-25","scope":"insider"},{"id":4772354,"accession":"0001104659-17-033537","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-17-033537","line_url":"/filing/0001104659-17-033537#line-6","is_derivative":false,"issuer_cik":"0001554194","issuer_name":"Nabriva Therapeutics AG","issuer_ticker":"NBRV","issuer_name_source":null,"issuer_url":"/issuer/0001554194","owner_cik":"0001554194","owner_name":"Talbot George Harrison","owner_url":"/insider/0001554194","role":"Director","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":103.0,"price_display":"103.00","price_state":"stated","total_value":10300.0,"total_display":"10,300.00","shares_owned_after":3884.0,"shares_owned_after_display":"3,884","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-16","filed_date":"2017-05-17","scope":"insider"},{"id":4772351,"accession":"0001104659-17-033537","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-17-033537","line_url":"/filing/0001104659-17-033537#line-5","is_derivative":false,"issuer_cik":"0001554194","issuer_name":"Nabriva Therapeutics AG","issuer_ticker":"NBRV","issuer_name_source":null,"issuer_url":"/issuer/0001554194","owner_cik":"0001554194","owner_name":"Talbot George Harrison","owner_url":"/insider/0001554194","role":"Director","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50.0,"shares_display":"50","price_per_share":102.268,"price_display":"102.27","price_state":"stated","total_value":5113.4,"total_display":"5,113.40","shares_owned_after":3984.0,"shares_owned_after_display":"3,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-16","filed_date":"2017-05-17","scope":"insider"},{"id":4772338,"accession":"0001104659-17-033537","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-17-033537","line_url":"/filing/0001104659-17-033537#line-4","is_derivative":false,"issuer_cik":"0001554194","issuer_name":"Nabriva Therapeutics AG","issuer_ticker":"NBRV","issuer_name_source":null,"issuer_url":"/issuer/0001554194","owner_cik":"0001554194","owner_name":"Talbot George Harrison","owner_url":"/insider/0001554194","role":"Director","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50.0,"shares_display":"50","price_per_share":101.5,"price_display":"101.50","price_state":"stated","total_value":5075.0,"total_display":"5,075.00","shares_owned_after":4034.0,"shares_owned_after_display":"4,034","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-15","filed_date":"2017-05-17","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001641640","name":"Nabriva Therapeutics plc","url":"/issuer/0001641640","role":"Director","n_filings":5,"first_seen":"2017-05-17","last_seen":"2018-08-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001554194","retrieved_at":"2026-08-21T04:41:54+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}